- Home
- ETON vs KTF Comparison
ETON vs KTF Comparison
Compare ETON & KTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ETON | KTF |
|---|---|---|
| Founded | 2017 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 411.9M | 358.0M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | ETON | KTF |
|---|---|---|
| Price | $18.95 | $9.16 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $31.00 | N/A |
| AVG Volume (30 Days) | ★ 294.8K | 84.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.54% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.39 |
| Revenue | ★ $39,011,000.00 | N/A |
| Revenue This Year | $107.23 | N/A |
| Revenue Next Year | $29.72 | N/A |
| P/E Ratio | ★ N/A | $23.47 |
| Revenue Growth | ★ 23.29 | N/A |
| 52 Week Low | $11.09 | $8.48 |
| 52 Week High | $23.00 | $9.50 |
Technical Indicators
Market Signals| Indicator | ETON | KTF |
|---|---|---|
| Relative Strength Index (RSI) | 65.46 | 43.77 |
| Support Level | $16.04 | $9.13 |
| Resistance Level | $20.01 | $9.28 |
| Average True Range (ATR) | 1.07 | 0.04 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 70.28 | 5.56 |
Price Performance
Historical ComparisonAbout ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About KTF DWS Municipal Income Trust
DWS Municipal Income Trust is a closed-ended fixed income mutual fund launched and managed by Deutsche Investment Management Americas, Inc. The company invests in the fixed income markets of the United States. The fund invests in investment-grade tax-exempt municipal securities which are exempt from federal income tax. The fund benchmarks the performance of its portfolio against the Barclays Municipal Bond Index. The Fund invests in various states, such as Texas, Florida, Pennsylvania, Illinois, and California.